Clinical trial Recruiting at 1 site Observational Ages 13 to 55 Women only

Cryopreservation of ovarian tissue and its effects on ovarian function

Official title: Cryopreservation Of Ovarian Tissue: Assessment Of Reimplantation Rate And Effects On Ovarian Function

Run by IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06835088 · Data updated 2026-11-12

This study tests if freezing and later reimplanting ovarian tissue can help women with premature ovarian failure, often caused by cancer treatments, regain their ovarian function.

Quick facts

Study typeObservational
Ages13 Years to 55 Years
SexWomen only
Enrollment400 (estimated)
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Bologna)
StatusRecruiting
StartedSeptember 12, 2021
Main results expectedDecember 31, 2030
Study endsDecember 30, 2031
Registry record updatedFebruary 19, 2025
Trial IDNCT06835088 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are women aged 13-55 who require gonadotropic treatments and have undergone ovarian tissue cryopreservation.

Probably not a fit

Patients with active oncological pathology or relapse may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on the cryopreservation of ovarian tissue in patients facing premature ovarian failure (POI) due to gonadotoxic treatments like chemotherapy and radiotherapy. It aims to evaluate the reimplantation rate of the cryopreserved ovarian tissue and its subsequent effects on ovarian function. The study includes patients aged 13-55 who have undergone ovarian tissue sampling and cryopreservation at a specific medical facility. The findings could provide insights into the effectiveness of this fertility preservation method for cancer patients.

Why it matters

Potential benefit: If successful, this study could enhance fertility preservation options for cancer patients facing premature ovarian failure.

How similar studies have gone: While the approach of ovarian tissue cryopreservation has been explored, this specific observational study aims to provide further insights into its effectiveness, making it a valuable addition to existing literature.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age: 13-55 years
* Suffering from diseases that require gonadotropic treatments
* Have been subjected to sampling and cryopreservation of ovarian tissue at the Operative Unit of Gynecology and Pathophysiology of Human Reproduction of the Sant'Orsola Polyclinic in Bologna
* Informed Consent Acquisition

Exclusion Criteria:

\- Oncological pathology still active or relapse

Where it's running

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna
    Bologna, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.